Search Results 1011-1020 of 21251 for Informed consent

1. A Study to Compare FEIBA to Alternative Blood Products in Treating Children After Cardiac Surgery - Mayo Clinic

   Availability and willingness of the parent/legal guardian to provide informed consent. Exclusion Criteria: Presence of mechanical circulatory support at the ...

2. Publications - Krishnan Ramanujan, M.D. - Mayo Clinic

   Informed Consent Practices in Anesthesiology: A National Survey of Informed Consent Preferences and Perceptions Among Practicing Anesthesiologists. Int ...

3. A Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection - Mayo Clinic

   Able and willing to provide written informed consent. Subjects with a qualifying CDI episode who have a prior history of CDI diarrhea or first occurrence of ...

4. Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant - Mayo Clinic

   Willing and able to give written informed consent; Vaccinated against Neisseria meningitides (quadrivalent vaccine), Pneumococcus and H. influenzae at least ...

5. Study Using Chromogranin A As Surveillance Biomarker In Patients With CARcinoids - Mayo Clinic

   Written informed consent signed. Exclusion Criteria: Other active malignancy with the exclusion of melanoma or other cancers that occurred more than 5 years ...

6. A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca - Mayo Clinic

   Able and willing to provide written informed consent; Willingness to return ... Willing to sign consent onto the Mayo Clinic Radiotherapy Patient ...

7. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

   Be ≥18 years of age and willing to provide written informed consent; For women and men of childbearing potential, have used effective contraceptive methods ...

8. Testing The Use Of Ado-Trastuzumab Emtansine Compared To The Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) For Recurrent, Metastatic, Or Unresectable HER2-Positive Salivary Gland Cancer - Mayo Clinic

   informed consent prior to study entry and, for patients treated in the U.S., authorization permitting release of personal health information. Exclusion ...

9. A Global Study To Assess The Drug Dynamics, Efficacy, And Safety Of GZ/SAR402671 In Parkinson's Disease Patients Carrying A Glucocerebrosidase (GBA) Gene Mutation - Mayo Clinic

   Age ≥18 years to 80 years inclusive at the time of informed consent signing. Has symptoms of PD ≥2 years. Hoehn and Yahr (H and Y) stage of 2 or lower at ...

10. A Study Of APL-2 Therapy In Patients With Geographic Atrophy Associated With Age-Related Macular Degeneration - Mayo Clinic

    Willing and able to give informed consent. Exclusion Criteria: Unless specified otherwise, ocular specific inclusion criteria apply to the study eye only ...